Stay updated on PD1-Vaxx B-Cell Immunotherapy in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the PD1-Vaxx B-Cell Immunotherapy in Lung Cancer Clinical Trial page.

Latest updates to the PD1-Vaxx B-Cell Immunotherapy in Lung Cancer Clinical Trial page
- Check4 days agoChange DetectedA new revision v3.5.0 was added to the Record History, and the previous revision v3.4.3 was removed.SummaryDifference0.1%

- Check11 days agoChange DetectedDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedA new revision entry (v3.4.2) was added, and outdated notices about funding and operating status (including v3.4.1) were removed. These updates concern the site’s version history and notices rather than the study details.SummaryDifference0.7%

- Check46 days agoChange DetectedA government funding status notice was added to the page. The latest record revision is v3.4.1, and the previous revision v3.4.0 was deleted.SummaryDifference1%

- Check54 days agoChange DetectedAdded a glossary display option and color-coded legends for additions and deletions; included guidance on change highlighting, and updated the revision tag from v3.3.4 to v3.4.0 with No FEAR Act wording adjustment.SummaryDifference0.9%

- Check89 days agoChange DetectedRevision: v3.3.3 has been added to the history. The entries for HHS Vulnerability Disclosure and Revision: v3.3.2 were removed.SummaryDifference0.2%

Stay in the know with updates to PD1-Vaxx B-Cell Immunotherapy in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PD1-Vaxx B-Cell Immunotherapy in Lung Cancer Clinical Trial page.